Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
28S ribosomal protein S21, mitochondrial (MRPS21) is a nuclear-encoded protein that forms part of the small 28S subunit of the mammalian mitochondrial ribosome (mitoribosome). MRPS21 assists in mitochondrial translation, enabling the synthesis of 13 essential proteins encoded by mitochondrial DNA that are required for oxidative phosphorylation and cellular energy production. Mitochondrial ribosomes (28S small + 39S large subunits) differ in composition from prokaryotic ribosomes and are characterized by a higher protein/rRNA ratio and unique sequence and structural features that are critical for mitochondrial-specific translational needs. Mutations or reduced expression of MRPS21 and other mitochondrial ribosomal proteins can result in mitochondrial dysfunction and have been associated with inherited human disorders such as combined oxidative phosphorylation deficiency[1][2][3][6]. There is currently no evidence that MRPS21 is a direct drug target nor associated with specific pharmacological agents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 28S ribosomal protein S21, mitochondrial (MRPS21).